Patents by Inventor Ki Keum

Ki Keum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050170417
    Abstract: Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.
    Type: Application
    Filed: February 16, 2005
    Publication date: August 4, 2005
    Inventors: Sang Lee, Nae Yoo, So Yoo, Hyun Chung, Ki Keum, Won Yoo, Ki Jeong
  • Publication number: 20050158810
    Abstract: Disclosed are a method, a composition, a microarray, an antibody and a kit for diagnosis and prognosis of cancer, based on detection of deletion of the exon 3 region of G-CSF gene or levels of a mutated G-CSF protein having a deletion of an amino acid sequence corresponding to the exon 3 region, wherein the deletion of the exon 3 region of the G-CSF gene is used as a cancer biomarker.
    Type: Application
    Filed: February 16, 2005
    Publication date: July 21, 2005
    Inventors: Sang Lee, Nae Yoo, So Yoo, Hyun Chung, Ki Keum, Won Yoo, Ki Jeong
  • Publication number: 20050142208
    Abstract: The present invention relates to a pharmaceutical composition for the treatment of wounds containing blood plasma or serum and a method for treating wounds effectively by applying said composition to the wound site to normalize the tissue-environment around the site.
    Type: Application
    Filed: May 9, 2003
    Publication date: June 30, 2005
    Inventors: Won Min Yoo, Kyung Chang, Nae Yoo, Ki Keum, Sang Lee, Gene Lee
  • Publication number: 20050136126
    Abstract: The present invention relates to an agent for reducing scar formation, which inhibits the scar formation by injecting sodium bicarbonate to the dermis tissue of the wound with a syringe to directly control pH of the wound site, namely, by alkalinizing the wound to inactivate TGF-?. According to the present invention, the agent for reducing scar formation by controlling the wound healing process can be clinically and immediately applied to the treatment of tylosis scar and keloid, etc., and is effective to the treatment of intractable fibrosis diseases. Also, the invention can be widely applied in many ways as an easy tool which can control the action of TGF-? in a living organism.
    Type: Application
    Filed: January 3, 2005
    Publication date: June 23, 2005
    Inventors: Ki Keum, Naechoon Yoo, Won-min Yoo